Pathological features of vessel co-option versus sprouting angiogenesis

[1]  R. Kerbel,et al.  Vessel co-option in cancer , 2019, Nature Reviews Clinical Oncology.

[2]  H. Nakshatri,et al.  Flower isoforms promote competitive growth in cancer , 2019, Nature.

[3]  P. Vermeulen,et al.  Histopathological growth patterns of colorectal liver metastasis exhibit little heterogeneity and can be determined with a high diagnostic accuracy , 2019, Clinical & Experimental Metastasis.

[4]  D. Nguyen,et al.  Transcriptomic Hallmarks of Tumor Plasticity and Stromal Interactions in Brain Metastasis , 2019, Cell reports.

[5]  Z. Szallasi,et al.  Origin and Distribution of Connective Tissue and Pericytes Impacting Vascularization in Brain Metastases With Different Growth Patterns , 2019, Journal of neuropathology and experimental neurology.

[6]  H. Moch,et al.  Eight autopsy cases of melanoma brain metastases showing angiotropism and pericytic mimicry. Implications for extravascular migratory metastasis , 2019, Journal of cutaneous pathology.

[7]  B. Stanger,et al.  The tumor as organizer model , 2019, Science.

[8]  P. Vermeulen,et al.  Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns , 2019, Clinical & Experimental Metastasis.

[9]  P. Vermeulen,et al.  Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases , 2019, Angiogenesis.

[10]  P. van Dam,et al.  Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy. , 2018, Seminars in cancer biology.

[11]  G. Bergers,et al.  The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer. , 2018, Seminars in cancer biology.

[12]  V. Servois,et al.  Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases , 2018, The journal of pathology. Clinical research.

[13]  M. Rosenblum,et al.  Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization , 2018, Nature Cell Biology.

[14]  B. Döme,et al.  Role of (myo)fibroblasts in the development of vascular and connective tissue structure of the C38 colorectal cancer in mice , 2018, Cancer communications.

[15]  B. Bozóky,et al.  Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review , 2018, BMJ open gastroenterology.

[16]  A. Harris,et al.  Non-angiogenic tumours and their influence on cancer biology , 2018, Nature Reviews Cancer.

[17]  G. Yousef,et al.  Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis , 2017, Oncotarget.

[18]  Yves Sucaet,et al.  International consensus guidelines for scoring the histopathological growth patterns of liver metastasis , 2017, British Journal of Cancer.

[19]  H. Augustin,et al.  Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology , 2017, Science.

[20]  J. Larkin,et al.  Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models , 2016, The Journal of pathology.

[21]  G. G. Van den Eynden,et al.  Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases , 2016, Nature Medicine.

[22]  T. Rodríguez,et al.  Cell Competition and Its Role in the Regulation of Cell Fitness from Development to Cancer. , 2016, Developmental cell.

[23]  H. Kleinman,et al.  Imaging of Angiotropism/Vascular Co-Option in a Murine Model of Brain Melanoma: Implications for Melanoma Progression along Extravascular Pathways , 2016, Scientific Reports.

[24]  G. Tiegs,et al.  Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells , 2016, Cellular & Molecular Immunology.

[25]  A. Harris,et al.  Why some tumours trigger neovascularisation and others don’t: the story thus far , 2016, Chinese journal of cancer.

[26]  R. Jain,et al.  Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases. , 2015, Journal of the National Cancer Institute.

[27]  A. Cole,et al.  Hepatic progenitor cells of biliary origin with liver repopulation capacity , 2015, Nature Cell Biology.

[28]  J. Tímár,et al.  Mechanism of tumour vascularization in experimental lung metastases , 2015, The Journal of pathology.

[29]  S. Martinez,et al.  Glioblastoma: A Pathogenic Crosstalk between Tumor Cells and Pericytes , 2014, PloS one.

[30]  T. Mikkelsen,et al.  Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy12 , 2014, Neoplasia.

[31]  M. Kris,et al.  Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis , 2014, Cell.

[32]  Frank Winkler,et al.  Invasion patterns in brain metastases of solid cancers. , 2013, Neuro-oncology.

[33]  H. Kleinman,et al.  Could pericytic mimicry represent another type of melanoma cell plasticity with embryonic properties? , 2013, Pigment cell & melanoma research.

[34]  R. Jain.  Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  J. Pichler,et al.  Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases , 2012, Clinical and Experimental Metastasis.

[36]  J. A. van der Laak,et al.  Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2 , 2013, PloS one.

[37]  S. Vandenberg,et al.  Role of connexins in metastatic breast cancer and melanoma brain colonization , 2013, Journal of Cell Science.

[38]  L. Ellis,et al.  Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. , 2013, Cancer cell.

[39]  Csaba Bödör,et al.  Structural analysis of oval‐cell–mediated liver regeneration in rats , 2012, Hepatology.

[40]  Z. Dong,et al.  Claudin-2 Promotes Breast Cancer Liver Metastasis by Facilitating Tumor Cell Interactions with Hepatocytes , 2012, Molecular and Cellular Biology.

[41]  B. Döme,et al.  Lack of Angiogenesis in Experimental Brain Metastases , 2011, Journal of neuropathology and experimental neurology.

[42]  F. Pépin,et al.  Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes , 2011, Oncogene.

[43]  Matthias Hermes,et al.  Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration , 2010, Proceedings of the National Academy of Sciences.

[44]  N. Sibson,et al.  The Vascular Basement Membrane as “Soil” in Brain Metastasis , 2009, PloS one.

[45]  P Hahnfeldt,et al.  Migration rules: tumours are conglomerates of self-metastases , 2009, British Journal of Cancer.

[46]  Masahiro Inoue,et al.  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. , 2009, Cancer cell.

[47]  E. van Marck,et al.  Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes. , 2008, The Annals of thoracic surgery.

[48]  E. Crivellato,et al.  Contribution of endothelial cells to organogenesis: a modern reappraisal of an old Aristotelian concept , 2007, Journal of anatomy.

[49]  P. V. Van Schil,et al.  Distinct angiogenic and non‐angiogenic growth patterns of lung metastases from renal cell carcinoma , 2007, Histopathology.

[50]  D. L. Le Couteur,et al.  T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells , 2006, Hepatology.

[51]  K. Gatter,et al.  Is nonangiogenesis a novel pathway for cancer progression? A study using 3-dimensional tumour reconstructions , 2006, British Journal of Cancer.

[52]  M. Oertel,et al.  Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/progenitor cells. , 2006, Gastroenterology.

[53]  K. Allison,et al.  Radiographically occult, diffuse intrasinusoidal hepatic metastases from primary breast carcinomas: a clinicopathologic study of 3 autopsy cases. , 2004, Archives of pathology & laboratory medicine.

[54]  C. Lugassy,et al.  Angiotropic malignant melanoma and extravascular migratory metastasis: description of 36 cases with emphasis on a new mechanism of tumour spread , 2004, Pathology.

[55]  Pieter Wesseling,et al.  Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option , 2004, Clinical Cancer Research.

[56]  J. Weyler,et al.  Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer , 2004, British Journal of Cancer.

[57]  E. van Marck,et al.  Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia , 2004, British Journal of Cancer.

[58]  C. Degott,et al.  Angiogenesis and extracellular matrix remodelling in bronchioloalveolar carcinomas: distinctive patterns in mucinous and non‐mucinous tumours , 2004, Histopathology.

[59]  C. Colpaert,et al.  Cutaneous breast cancer deposits show distinct growth patterns with different degrees of angiogenesis, hypoxia and fibrin deposition , 2003, Histopathology.

[60]  A. Nicholson,et al.  Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas , 2002, British Journal of Cancer.

[61]  P. Wesseling,et al.  Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis. , 2002, Cancer research.

[62]  E. van Marck,et al.  Lack of angiogenesis in lymph node metastases of carcinomas is growth pattern‐dependent , 2002, Histopathology.

[63]  E. van Marck,et al.  Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia , 2001, The Journal of pathology.

[64]  J. Rossant,et al.  Liver Organogenesis Promoted by Endothelial Cells Prior to Vascular Function , 2001, Science.

[65]  H. Gröne,et al.  Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. , 2001, Cancer research.

[66]  R. Price,et al.  Evidence for novel non-angiogenic pathway in breast-cancer metastasis , 2000, The Lancet.

[67]  G. Yancopoulos,et al.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.

[68]  M Buyse,et al.  Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. , 1997, The American journal of pathology.

[69]  S. Love,et al.  ‘Revertant’ DCIS in human axillary breast carcinoma metastases , 1997, The Journal of pathology.

[70]  M. Buyse,et al.  Immunocytochemical markers in stage I lung cancer: relevance to prognosis. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  T. Terada,et al.  Histologic growth patterns of metastatic carcinomas of the liver. , 1996, Japanese journal of clinical oncology.

[72]  M. Kage,et al.  Pathomorphologic characteristics of small hepatocellular carcinoma: A special reference to small hepatocellular carcinoma with indistinct margins , 1995, Hepatology.

[73]  J. Risteli,et al.  Immunohistochemical Evidence that Lung Carcinomas Grow on Alveolar Basement Membranes , 1990, The American journal of surgical pathology.

[74]  Dr. Johannes Erichsen.  Zwei Fälle von Carcinosis acuta miliaris , 1861, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[75]  Tracy T Batchelor,et al.  Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. , 2011, Cancer research.

[76]  W. Leenders,et al.  Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis. , 2002, Endothelium : journal of endothelial cell research.